This project is part of the EDCTP3 programme supported by the European Union

Share:

Opinion: Malaria clinical research must include pregnant women

Malaria is a dangerous disease. One that, according to the World Health Organization, resulted in 249 million cases and 608,000 deaths in 2022 worldwide. For pregnant women, particularly those in their first trimester, it can cause serious complications, a concern for over 120 million women of childbearing age living in malaria-endemic areas. Malaria in pregnancy can result in maternal and neonatal mortality, miscarriage, low birth weight, and stillbirth.

United Nations member states adopted the Sustainable Development Goals in 2015, which include Goal 3 of ensuring healthy lives and promoting well-being for all at all ages, and Goal 5 of achieving gender equality and empowering all women and girls by 2030. The SDGs include specific targets for ending malaria, ending all forms of discrimination against women and girls, and achieving universal health coverage. However, medicines can take 20 years to be approved for use in pregnant women; time that the global health community does not have if it is to meet the 2030 deadline to achieve these goals.  

To view the full article, please visit the Devex website.

Subscribe to the SAFIRE newsletter

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.